Biomarin Pharmaceutical Inc
2013 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/13/2026 | 42,432 | 0.2% | 713,979 | 12/31/2025 |
| 2025 Q3 | 10/17/2025 | 38,668 | 0.2% | 713,956 | 9/30/2025 |
| 2025 Q2 | 7/17/2025 | 39,240 | 0.2% | 713,846 | 6/30/2025 |
| 2025 Q1 | 4/16/2025 | 50,547 | 0.3% | 715,049 | 3/31/2025 |
| 2024 Q4 | 1/17/2025 | 47,030 | 0.3% | 715,500 | 12/31/2024 |
| 2024 Q3 | 10/25/2024 | 51,148 | 0.3% | 727,670 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 80,571 | 0.5% | 978,638 | 6/30/2024 |
| 2024 Q1 | 5/13/2024 | 101,948 | 0.7% | 1,167,255 | 3/31/2024 |
| 2023 Q4 | 1/17/2024 | 112,386 | 0.8% | 1,165,589 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 115,754 | 0.9% | 1,308,245 | 9/30/2023 |
| 2023 Q2 | 7/28/2023 | 102,418 | 0.7% | 1,181,565 | 6/30/2023 |
| 2023 Q1 | 4/28/2023 | 111,321 | 0.8% | 1,144,811 | 3/31/2023 |
| 2022 Q4 | 1/30/2023 | 118,605 | 0.9% | 1,146,055 | 12/31/2022 |
| 2022 Q3 | 10/26/2022 | 97,112 | 0.8% | 1,145,596 | 9/30/2022 |
| 2022 Q2 | 8/5/2022 | 102,432 | 0.8% | 1,236,059 | 6/30/2022 |
| 2022 Q1 | 5/3/2022 | 95,219 | 0.6% | 1,235,009 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 101,040 | 0.6% | 1,143,631 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 45,748 | 0.3% | 591,902 | 9/30/2021 |
| 2014 Q1 | 5/13/2014 | 562 | 0.0% | 8,235 | 3/31/2014 |
| 2013 Q4 | 2/14/2014 | 6,235 | 0.1% | 88,630 | 12/31/2013 |